特发性肥厚性硬脑脊膜炎1例

doi:10.3760/cma.j.issn.1007-1245.2023.03.030

国际医药卫生导报 ›› 2023, Vol. 29 ›› Issue (3): 430-433.DOI: 10.3760/cma.j.issn.1007-1245.2023.03.030

特发性肥厚性硬脑脊膜炎1例

詹霞¹ 李志霞²

¹威海市中心医院神经内科，威海　264400；²山东大学齐鲁医院德州医院神经内科，德州　253400

收稿日期:2022-09-14 出版日期:2023-02-01 发布日期:2023-03-03
通讯作者: 詹霞，Email：859896878@qq.com

One case of idiopathic hypertrophic cranial and spinal pachymeningitis

Zhan Xia¹, Li Zhixia²

¹Department of Neurology, Weihai Central Hospital, Weihai 264400, China; ²Department of Neurology, Dezhou Hospital, Qilu Hospital of Shandong University, Dezhou 253400, China

Received:2022-09-14 Online:2023-02-01 Published:2023-03-03
Contact: Zhan Xia, Email: 859896878@qq.com

摘要/Abstract

摘要：

肥厚性硬膜炎（hypertrophic pachymeningitis，HP）是一种硬脊膜慢性纤维化炎性病变，该病临床少见，分为肥厚性硬脑膜炎（hypertrophic cranial pachymeningitis，HCP）、肥厚性硬脊膜炎（hypertrophic spinal pachymeningitis，HSP），两者可同时存在。分为继发性和特发性，很可能与免疫因素相关，治疗方法包括糖皮质激素等免疫抑制和手术。病理是诊断金标准，核磁增强表现可协助诊断。现报道威海市中心医院1例特发性肥厚性硬脑脊膜炎。

关键词:

特发性肥厚性硬脑脊膜炎, 磁共振成像, 免疫治疗

Abstract:

Hypertrophic pachymeningitis (HP) is a chronic fibrous inflammatory disease of the spinal dura, and is rare in clinic. It can be divided into hypertrophic cranial pachymeningitis (HCP) and hypertrophic spinal pachymeningitis (HSP), which can exist at the same time. It can be divided into secondary and idiopathic, which may be related to immune factors. The treatment methods include glucocorticoids and other immunosuppression and surgery. Pathology is the gold standard for diagnosis, and magnetic resonance imaging (MRI) enhancement may assist in diagnosis. A case of idiopathic hypertrophic cranial and spinal pachymeningitis in Weihai Central Hospital is reported now.

Key words:

Idiopathic hypertrophic cranial and spinal pachymeningitis, Magnetic resonance imaging, Immunotherapy

詹霞李志霞.

特发性肥厚性硬脑脊膜炎1例 [J]. 国际医药卫生导报, 2023, 29(3): 430-433.

Zhan Xia, Li Zhixia.

One case of idiopathic hypertrophic cranial and spinal pachymeningitis [J]. International Medicine and Health Guidance News, 2023, 29(3): 430-433.

参考文献

[1] Lu LX, Della-Torre E, Stone JH, et al. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment[J].JAMA Neurol,2014,71(6):785-793. DOI:10.1001/jamaneurol.2014.243.
[2] 解龙昌,黄如训. 肥厚性硬脑膜炎[J]. 中国神经精神疾病杂志,2003,29(2):155-157. DOI:10.3969/j.issn.1002-0152. 2003.02.047.
[3] Lowden MR, Gill D. Teaching NeuroImage: idiopathic hypertrophic spinal pachymeningitis[J].Neurology,2009,72(5):e27. DOI:10.1212/01.wnl.0000341880.99861.1e.
[4] Hsu HT, Hsu SS, Chien CC, et al. Teaching NeuroImages: idiopathic hypertrophic spinal pachymeningitis mimicking epidural lymphoma[J].Neurology,2015,84(9):e67-e68. DOI:10.1212/WNL.0000000000001314.
[5] van der Pol CB, Chakraborty S, Côté I, et al. Case 216: hypertrophic spinal pachymeningitis[J].Radiology,2015,275(1):303-307. DOI:10.1148/radiol.15122159.
[6] Yokoseki A, Saji E, Arakawa M, et al. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody[J].Brain,2014,137(Pt 2):520-536. DOI:10.1093/brain/awt314.
[7] Chan SK, Cheuk W, Chan KT, et al. IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease[J].Am J Surg Pathol,2009,33(8):1249-1252. DOI:10.1097/PAS.0b013e3181abdfc2.
[8] Nakamura T, Hirakawa K, Higashi S, et al. CD8+ T lymphocytes infiltrate predominantly in the inflammatory foci of MPO-ANCA-positive thoracic hypertrophic pachymeningitis in a patient with HLA-A24[J].Mod Rheumatol,2007,17(1):75-80. DOI:10.1007/s10165-006-0537-8.
[9] Muthukumar N, Senthilbabu S, Usharani K. Idiopathic hypertrophic cranial pachymeningitis masquerading as Tolosa-Hunt syndrome[J].J Clin Neurosci,2005,12(5):589-592. DOI:10.1016/j.jocn.2004.08.016.
[10] Muthukumar N, Senthilbabu S, Usharani K. Idiopathic hypertrophic cranial pachymeningitis masquerading as Tolosa-Hunt syndrome[J].J Clin Neurosci,2005,12(5):589-592. DOI:10.1016/j.jocn.2004.08.016.
[11] Kupersmith MJ, Martin V, Heller G, et al. Idiopathic hypertrophic pachymeningitis[J].Neurology,2004,62(5):686-694. DOI:10.1212/01.wnl.0000113748.53023.b7.
[12] 张海玲,董秦雯,熊斌,等. 影像呈结节状占位样的特发性肥厚性硬脑膜炎临床分析[J]. 中华内科杂志,2014,53(2):127-130. DOI:10.3760/cma.j.issn.0578-1426.2014. 02.012.
[13] Heckmann JG, Oberst G. Peace sign in calcified idiopathic hypertrophic pachymeningitis[J].Can J Neurol Sci,2014,41(2):265-266. DOI:10.1017/s0317167100016681.
[14] Bosman T, Simonin C, Launay D, et al. Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature[J].Rheumatol Int,2008,28(7):713-718. DOI:10.1007/s00296-007-0504-5.
[15] Kim JH, Park YM, Chin DK. Idiopathic hypertrophic spinal pachymeningitis: report of two cases and review of the literature[J].J Korean Neurosurg Soc,2011,50(4):392-395. DOI:10.3340/jkns.2011.50.4.392.

特发性肥厚性硬脑脊膜炎1例

One case of idiopathic hypertrophic cranial and spinal pachymeningitis

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

[1]	袁晓莉王振波. 食管鳞癌的肿瘤免疫微环境和免疫检查点抑制剂研究进展 [J]. 国际医药卫生导报, 2023, 29(3): 310-314.
[2]	凌娟曾慧兰. 双特异性抗体在复发难治多发性骨髓瘤中的治疗进展 [J]. 国际医药卫生导报, 2023, 29(3): 319-323.
[3]	苏慧超张臻唐晓慧于金明. 基于lncRNA模型预测宫颈癌免疫治疗应答 [J]. 国际医药卫生导报, 2023, 29(1): 34-.